FOXP3+ Macrophage-Derived Amphiregulin Promotes White Matter Repair of Experimental Autoimmune Encephalomyelitis

Shilin Wu1, Shishi Shen1, Wenxuan Sun1

  • 1Department of Neurology, Mental and Neurological Disease Research Center, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Insights

Macrophages that digest myelin debris in multiple sclerosis (MS) activate FOXP3 signaling, promoting nerve repair. This discovery highlights FOXP3+ macrophages as a potential therapeutic target for MS recovery.

Area of Science:

  • Neuroimmunology
  • Cellular plasticity in demyelinating diseases

Background:

  • Multiple sclerosis (MS) involves inflammatory demyelination and remyelination.
  • Macrophages are key players in both demyelination and remyelination.
  • The plasticity of macrophages in promoting MS remyelination is not well understood.

Purpose of the Study:

  • To investigate the role of FOXP3 signaling in macrophage plasticity during MS.
  • To identify mechanisms by which macrophages facilitate remyelination in MS.

Main Methods:

  • Generated macrophage-specific Foxp3 conditional knockout mice.
  • Analyzed the impact of FOXP3 signaling on macrophage phenotype and function.
  • Assessed the effect of FOXP3+ macrophages on oligodendrocyte progenitor cell differentiation and experimental autoimmune encephalomyelitis (EAE) recovery.

Main Results:

  • Digestion of myelin debris by macrophages activates FOXP3 signaling.
  • FOXP3 signaling induces a pro-regenerative macrophage phenotype.
  • FOXP3+ macrophages enhance oligodendrocyte progenitor cell differentiation via amphiregulin (AREG) production.
  • This mechanism improves recovery in experimental autoimmune encephalomyelitis.

Conclusions:

  • FOXP3+ macrophages play a crucial role in promoting remyelination and recovery in MS.
  • Macrophage-derived amphiregulin (AREG) mediates the pro-regenerative effects.
  • Targeting FOXP3+ macrophages represents a potential therapeutic strategy for MS.